These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 22901393)
1. Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase. Kim IH; Nishi K; Kasagami T; Morisseau C; Liu JY; Tsai HJ; Hammock BD Bioorg Med Chem Lett; 2012 Sep; 22(18):5889-92. PubMed ID: 22901393 [TBL] [Abstract][Full Text] [Related]
2. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors. Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357 [TBL] [Abstract][Full Text] [Related]
3. Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase. Mahlooji I; Shokri M; Manoochehri R; Mahboubi-Rabbani M; Rezaee E; Tabatabai SA Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000052. PubMed ID: 32484272 [TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain. Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552 [TBL] [Abstract][Full Text] [Related]
5. Imidazolidine-2,4,5- and pirimidine-2,4,6-triones - New primary pharmacophore for soluble epoxide hydrolase inhibitors with enhanced water solubility. Burmistrov V; Morisseau C; D'yachenko V; Karlov D; Butov GM; Hammock BD Bioorg Med Chem Lett; 2020 Feb; 30(3):126908. PubMed ID: 31870649 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides. Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of amide-phosphonate derivatives as inhibitors of the human soluble epoxide hydrolase. Kim IH; Park YK; Nishiwaki H; Hammock BD; Nishi K Bioorg Med Chem; 2015 Nov; 23(22):7199-210. PubMed ID: 26507430 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase. Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964 [TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase. Taylor SJ; Soleymanzadeh F; Eldrup AB; Farrow NA; Muegge I; Kukulka A; Kabcenell AK; De Lombaert S Bioorg Med Chem Lett; 2009 Oct; 19(20):5864-8. PubMed ID: 19758802 [TBL] [Abstract][Full Text] [Related]
10. Identification of potent inhibitors of the chicken soluble epoxide hydrolase. Shihadih DS; Harris TR; Yang J; Merzlikin O; Lee KS; Hammock BD; Morisseau C Bioorg Med Chem Lett; 2015 Jan; 25(2):276-9. PubMed ID: 25479771 [TBL] [Abstract][Full Text] [Related]
11. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores. Scholz MS; Wingen LM; Brunst S; Wittmann SK; Cardoso ILA; Weizel L; Proschak E Eur J Med Chem; 2020 Jan; 185():111766. PubMed ID: 31677445 [TBL] [Abstract][Full Text] [Related]
12. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation. Hejazi L; Rezaee E; Tabatabai SA Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350 [TBL] [Abstract][Full Text] [Related]
16. The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase. Li HY; Jin Y; Morisseau C; Hammock BD; Long YQ Bioorg Med Chem; 2006 Oct; 14(19):6586-92. PubMed ID: 16784862 [TBL] [Abstract][Full Text] [Related]
17. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs). Das N; Dhanawat M; Kulshrestha A; Shrivastava SK Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298 [TBL] [Abstract][Full Text] [Related]
19. Development of potent inhibitors of the human microsomal epoxide hydrolase. Barnych B; Singh N; Negrel S; Zhang Y; Magis D; Roux C; Hua X; Ding Z; Morisseau C; Tantillo DJ; Siegel JB; Hammock BD Eur J Med Chem; 2020 May; 193():112206. PubMed ID: 32203787 [TBL] [Abstract][Full Text] [Related]
20. Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe. Sun YN; Kim JH; Li W; Jo AR; Yan XT; Yang SY; Kim YH Bioorg Med Chem; 2015 Oct; 23(20):6659-65. PubMed ID: 26372074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]